[Decisional algorithm to prescribe vitamin K antagonist in geriatric patients with atrial fibrillation]

Insights

An algorithm aids prescribing vitamin K antagonists (VKA) for atrial fibrillation (AF) in elderly patients. This tool improves VKA decisions, potentially preventing prescriptions in those with poorer prognoses.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Pharmacology

Context:

  • Atrial fibrillation (AF) management in geriatric patients presents challenges for anticoagulant therapy.
  • Prescribing vitamin K antagonists (VKA) requires careful consideration due to increased risks in the elderly.
  • Existing guidelines may not fully address the complexities of VKA use in this population.

Purpose:

  • To develop and evaluate an algorithm for optimizing VKA prescription in elderly AF patients.
  • To identify key criteria influencing VKA decision-making in this demographic.
  • To assess the algorithm's impact on prescription patterns and patient outcomes.

Summary:

  • A 6-criterion algorithm was developed to guide VKA prescription for AF in elderly patients (mean age 86.1).
  • Criteria included bleeding history, autonomy, cognitive function (MMSE), fall risk, and comorbidities.
  • The algorithm guided VKA prescription in 60.1% of patients, with lower rates in the oldest old.

Impact:

  • The algorithm facilitates objective VKA prescription decisions in geriatric AF patients.
  • Follow-up data showed no VKA-related bleeding events.
  • Non-prescription of VKA was associated with higher mortality, suggesting the algorithm may prevent inappropriate prescriptions.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
382